Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

47 trials with published results (18%)

Research Maturity

133 completed trials (52% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

7.8%

20 terminated out of 258 trials

Success Rate

86.9%

+0.4% vs benchmark

Late-Stage Pipeline

5%

12 trials in Phase 3/4

Results Transparency

35%

47 of 133 completed with results

Key Signals

47 with results87% success20 terminated

Data Visualizations

Phase Distribution

178Total
Not Applicable (99)
Early P 1 (8)
P 1 (23)
P 2 (36)
P 3 (8)
P 4 (4)

Trial Status

Completed133
Recruiting45
Unknown22
Terminated20
Active Not Recruiting16
Withdrawn11

Trial Success Rate

86.9%

Benchmark: 86.5%

Based on 133 completed trials

Clinical Trials (258)

Showing 20 of 20 trials
NCT06384924RecruitingPrimary

Raman Spectroscopy and Skin Cancer

NCT03503240Enrolling By InvitationPrimary

Patient Satisfaction With Appearance, Scar Outcome and Quality of Life After Skin Cancer Surgery

NCT02012699Recruiting

Integrated Cancer Repository for Cancer Research

NCT06379581SuspendedPrimary

Skin Cancer Diagnostics Using Photoacoustic Imaging

NCT05520099Active Not Recruiting

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform

NCT04064424Not ApplicableWithdrawnPrimary

Cancer Prevention & Online Technologies

NCT06362369Phase 1Recruiting

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

NCT07286318Early Phase 1Not Yet RecruitingPrimary

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

NCT06298734Not ApplicableRecruiting

High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial

NCT07349940Not ApplicableRecruiting

Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care

NCT05702398Early Phase 1RecruitingPrimary

Pilot Trial of Supplemental Vitamin A and Nicotinamide

NCT05774600Not ApplicableCompletedPrimary

Virtual Sun Safe Workplaces Ph II (SSW Works)

NCT06926075Phase 1Recruiting

Early Phase Study of KESONOTIDE™in Participants With Solid Tumours

NCT03071406Phase 2Active Not Recruiting

Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma

NCT06167096Not ApplicableCompletedPrimary

Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery

NCT07436390Not ApplicableCompleted

IFN-Gamma Expression as a Predictor of Response to Immune Checkpoint Inhibitors in First-Line Metastatic Melanoma

NCT02721459Phase 1Active Not Recruiting

XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma

NCT03716193Not ApplicableTerminated

Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry

NCT07422805Not ApplicableCompleted

Circulating Tumor DNA in Melanoma Patients

NCT07429123Completed

Using an Artificial Intelligence Medical Device to Help Primary Care Practitioners Identify and Manage Skin Conditions (Tumor, Inflammatory, and Infectious Diseases) in Adult Patients at Pozuelo and Majadahonda Health Centers

Scroll to load more

Research Network

Activity Timeline